NEUROUROLOGY AND URODYNAMICS, cilt.37, sa.1, ss.263-268, 2018 (SCI-Expanded)
AimsTo investigate the efficacy and safety of intradetrusor onabotulinumtoxinA (onaBoNT-A) injection in patients with overactive bladder (OAB) refractory to antimuscarinic treatment.